| Dr Panayiotis Vasiloudes, MD, PHD | |
|
5210 Webb Rd, Tampa, FL 33615-4518 | |
| (813) 882-9986 | |
| (813) 882-9849 |
| Full Name | Dr Panayiotis Vasiloudes |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 35 Years |
| Location | 5210 Webb Rd, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134129505 | NPI | - | NPPES |
| 269815300 | Medicaid | FL |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Academic Alliance In Dermatology Inc | 8729077938 | 26 |
News Archive
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
The answer for Tibetans who live at altitudes around 14,000 feet is increased nitric oxide (NO) levels. High levels of NO circulate in various forms in the blood and produce the physiological mechanisms that cause the increased blood flow that maintains oxygen delivery despite hypoxia - low levels of oxygen in the ambient air and the bloodstream.
Nearly 66 percent of all adverse events experienced by nursing home residents, such as falls, delirium and hallucinations, could be prevented, in part, by monitoring medication more closely. In nursing homes, both registered nurses (RNs) and licensed practical nurses (LPNs) perform medication reconciliation, a safety practice during which health care professionals review patients' medications to reduce the likelihood of preventable adverse drug events.
Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in the development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with the disease.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
› Verified 2 days ago
| Entity Name | Academic Alliance In Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538119722 PECOS PAC ID: 8729077938 Enrollment ID: O20040511001288 |
News Archive
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
The answer for Tibetans who live at altitudes around 14,000 feet is increased nitric oxide (NO) levels. High levels of NO circulate in various forms in the blood and produce the physiological mechanisms that cause the increased blood flow that maintains oxygen delivery despite hypoxia - low levels of oxygen in the ambient air and the bloodstream.
Nearly 66 percent of all adverse events experienced by nursing home residents, such as falls, delirium and hallucinations, could be prevented, in part, by monitoring medication more closely. In nursing homes, both registered nurses (RNs) and licensed practical nurses (LPNs) perform medication reconciliation, a safety practice during which health care professionals review patients' medications to reduce the likelihood of preventable adverse drug events.
Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in the development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with the disease.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Panayiotis Vasiloudes, MD, PHD 5210 Webb Rd, Tampa, FL 33615-4518 Ph: (813) 882-9986 | Dr Panayiotis Vasiloudes, MD, PHD 5210 Webb Rd, Tampa, FL 33615-4518 Ph: (813) 882-9986 |
News Archive
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line treatment of patients with squamous cell cancer of the head and neck.
The answer for Tibetans who live at altitudes around 14,000 feet is increased nitric oxide (NO) levels. High levels of NO circulate in various forms in the blood and produce the physiological mechanisms that cause the increased blood flow that maintains oxygen delivery despite hypoxia - low levels of oxygen in the ambient air and the bloodstream.
Nearly 66 percent of all adverse events experienced by nursing home residents, such as falls, delirium and hallucinations, could be prevented, in part, by monitoring medication more closely. In nursing homes, both registered nurses (RNs) and licensed practical nurses (LPNs) perform medication reconciliation, a safety practice during which health care professionals review patients' medications to reduce the likelihood of preventable adverse drug events.
Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in the development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with the disease.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
› Verified 2 days ago
Dr. Scott Forrester Lindsey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 310 S. Macdill Ave., Suite 201, Tampa, FL 33609 Phone: 813-609-3810 Fax: 813-559-1846 | |
Dr. Alan M Freedman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4412 W Osborne Ave, Tampa, FL 33614 Phone: 813-914-9100 Fax: 239-278-1159 | |
Philip Shenefelt, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 12901 Bruce B Downs Blvd, Mdc 79, Tampa, FL 33612 Phone: 813-974-2920 | |
Dr. Henry E Wiley Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1425 S Howard Ave, Tampa, FL 33606 Phone: 813-253-2635 Fax: 813-254-7142 | |
Ferwa Mohammed, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1208 E Kennedy Blvd Ste 221, Tampa, FL 33602 Phone: 813-590-6868 | |
Dr. Salma Z Pothiawala, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15310 Amberly Dr, Suite 150, Tampa, FL 33647 Phone: 813-978-8888 Fax: 813-972-8974 | |
Brianna Castillo, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 11601 Sheldon Rd, Tampa, FL 33626 Phone: 813-324-6630 Fax: 813-926-1500 |